JP2007506742A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506742A5
JP2007506742A5 JP2006528071A JP2006528071A JP2007506742A5 JP 2007506742 A5 JP2007506742 A5 JP 2007506742A5 JP 2006528071 A JP2006528071 A JP 2006528071A JP 2006528071 A JP2006528071 A JP 2006528071A JP 2007506742 A5 JP2007506742 A5 JP 2007506742A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
methoxy
phenyl
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006528071A
Other languages
English (en)
Japanese (ja)
Other versions
JP4719681B2 (ja
JP2007506742A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/030483 external-priority patent/WO2005030217A1/en
Publication of JP2007506742A publication Critical patent/JP2007506742A/ja
Publication of JP2007506742A5 publication Critical patent/JP2007506742A5/ja
Application granted granted Critical
Publication of JP4719681B2 publication Critical patent/JP4719681B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006528071A 2003-09-23 2004-09-17 キナゾリンカリウムチャネル阻害剤 Expired - Fee Related JP4719681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50513903P 2003-09-23 2003-09-23
US60/505,139 2003-09-23
PCT/US2004/030483 WO2005030217A1 (en) 2003-09-23 2004-09-17 Quinazoline potassium channel inhibitors

Publications (3)

Publication Number Publication Date
JP2007506742A JP2007506742A (ja) 2007-03-22
JP2007506742A5 true JP2007506742A5 (cg-RX-API-DMAC7.html) 2007-08-02
JP4719681B2 JP4719681B2 (ja) 2011-07-06

Family

ID=34392984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006528071A Expired - Fee Related JP4719681B2 (ja) 2003-09-23 2004-09-17 キナゾリンカリウムチャネル阻害剤

Country Status (8)

Country Link
US (1) US7906521B2 (cg-RX-API-DMAC7.html)
EP (1) EP1667685B1 (cg-RX-API-DMAC7.html)
JP (1) JP4719681B2 (cg-RX-API-DMAC7.html)
CN (1) CN1856310A (cg-RX-API-DMAC7.html)
AT (1) ATE549024T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004275718B2 (cg-RX-API-DMAC7.html)
CA (1) CA2539476C (cg-RX-API-DMAC7.html)
WO (1) WO2005030217A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
CA2575003C (en) 2004-07-29 2010-02-16 Merck & Co., Inc. Potassium channel inhibitors
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
BRPI0608343A2 (pt) * 2005-03-09 2016-10-04 Merck & Co Inc composto, composição farmacêutica, e, métodos para tratamento ou controle de uma doença ou condição, para intensificação da qualidade do sono, para aumento de sono rem e do sono de onda lenta, para diminuição da fragmentação de padrões do sono, para intensificação de cognição, para aumento da retenção de memória, e, para tratamento, controle, melhora ou redução do risco de esquizofrenia em um paciente mamífero em necessidade destes
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
WO2007098386A1 (en) * 2006-02-17 2007-08-30 Janssen Pharmaceutica N.V. Pyrazolylquinazolinones as potassium channel openers
DE102006019589A1 (de) * 2006-04-27 2007-10-31 Sanofi-Aventis Deutschland Gmbh Inhibitoren des TASK-1 und Task-3 Ionenkanals
WO2008112320A1 (en) * 2007-03-15 2008-09-18 The Trustees Of The University Of Pennsylvania Inhibition of ion channel function
CA2692783A1 (en) * 2007-07-10 2009-01-15 Merck Sharp & Dohme Corp. Quinazolinone t-type calcium channel antagonists
CN101654441B (zh) * 2008-08-19 2012-10-03 信谊药厂 抗凝化合物、组合物及其用途
WO2010088195A1 (en) * 2009-01-30 2010-08-05 Boehringer Ingelheim International Gmbh Azaquinazolinediones useful as chymase inhibitors
PT2473487T (pt) 2009-09-03 2017-01-04 Bristol Myers Squibb Co Quinazolinas como inibidores dos canais iónicos de potássio
CN103130730B (zh) * 2011-11-24 2015-04-08 南开大学 喹唑啉类衍生物及其制备方法、抗hiv活性和抗tmv活性
HUE041418T2 (hu) * 2013-08-29 2019-05-28 Kyoto Pharma Ind Aromás vegyületek és alkalmazásuk csont metabolizmushoz kapcsolódó rendellenességek kezelésére
EP3043790B1 (en) 2013-09-11 2021-05-26 The Administrators of the Tulane Educational Fund Novel anthranilic amides and the use thereof
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311573A (en) 1970-04-27 1973-03-28 Hisamitsu Pharmaceutical Co Quinazolinedione derivatives
GB1491510A (en) * 1973-12-14 1977-11-09 Hisamitsu Pharmaceutical Co 1-nitrophenylquinazoline-2,4(1h,3h)-diones
JPS6020387B2 (ja) * 1975-12-26 1985-05-21 久光製薬株式会社 新規なキナゾリン誘導体の製造法
LU74369A1 (cg-RX-API-DMAC7.html) 1976-02-18 1977-09-12
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
US5891904A (en) * 1992-09-14 1999-04-06 Wolf-Georg Forssmann Use of inhibitors of phosphodiesterase IV
ATE178210T1 (de) * 1992-09-14 1999-04-15 Forssmann Wolf Georg Prof Dr Neue verwendung von inhibitoren der phosphodiesterase iv
HUT76640A (en) * 1995-08-17 1997-10-28 Chinoin Gyogyszer Es Vegyeszet Compounds of pharmaceutical activity cyclic amide derivatives, pharmaceutical compositions containing them, process for producing them and their use
US6054487A (en) * 1997-03-18 2000-04-25 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
US6037345A (en) * 1998-01-13 2000-03-14 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives
US6870055B2 (en) 2000-09-20 2005-03-22 Merck & Co., Inc. Isoquinolinone potassium channels inhibitors
CN1988907B (zh) 2004-06-01 2010-12-22 弗吉尼亚大学专利基金会 癌瘤及血管生成的双重小分子抑制剂

Similar Documents

Publication Publication Date Title
JP2007506742A5 (cg-RX-API-DMAC7.html)
JP2007516218A5 (cg-RX-API-DMAC7.html)
JP2007506748A5 (cg-RX-API-DMAC7.html)
Thompson et al. Perioperative cardiac arrhythmias
Javed et al. Cardiovascular pharmacology
WO2008073392A3 (en) Compositions and methods for cardiac tissue protection and regeneration
ATE338549T1 (de) Therapeutische zusammensetzung von amlodipin und benazepril / benazeprilat
CA2539476A1 (en) Quinazoline potassium channel inhibitors
JP2011068661A (ja) 洞房結節Ｉｆ電流阻害剤およびカルシウム阻害剤の新規な組み合わせならびにそれを含む医薬組成物
NO20070522L (no) Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper
RU2005110917A (ru) Клопидогрел
JP2021504466A5 (cg-RX-API-DMAC7.html)
NO20070147L (no) Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen
Kumar et al. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists
MY138896A (en) Derivatives of 3-(guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom
Wynn Cardiovascular drugs and dental considerations
JP2007527903A5 (cg-RX-API-DMAC7.html)
Andrikopoulos et al. Ivabradine: a selective if current inhibitor in the treatment of stable angina
CA2590224A1 (en) Method for reduction, stabilization and prevention of rupture of lipid rich plaque
Cleophas et al. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review
Borghi et al. LIFE (losartan intervention for endpoint reduction in hypertension) study and its substudies
NO20016127L (no) Nye bisbidinforbindelser som er nyttige i behandlingen av hjertearytmier
NO20016117D0 (no) Nye bispidinforbindelser som er nyttige i behandlingen av hjertearytmier
Kijtawornrat et al. Effects of ambasilide in isolated perfused guinea pig heart: use dependence
Abraham et al. Medical management of mild-to-moderate heart failure before the advent of beta blockers